D.E. Shaw & Co’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-85,466
| Closed | -$7.26M | – | 4474 |
|
|
2019
Q4 | $7.26M | Buy |
85,466
+77,201
| +934% | +$5.15M | 0.01% | 1443 |
|
|
2019
Q3 | $413K | Buy |
+8,265
| New | +$330K | ﹤0.01% | 3302 |
|
|
2017
Q4 | – | Sell |
-9,064
| Closed | -$279K | – | 3830 |
|
|
2017
Q3 | $336K | Buy |
+9,064
| New | +$334K | ﹤0.01% | 3099 |
|
|
2017
Q2 | – | Sell |
-38,125
| Closed | -$1.7M | – | 3625 |
|
|
2017
Q1 | $1.86M | Sell |
38,125
-132,827
| -78% | -$6.06M | ﹤0.01% | 1890 |
|
|
2016
Q4 | $5.8M | Sell |
170,952
-23,810
| -12% | -$844K | 0.01% | 1269 |
|
|
2016
Q3 | $7.35M | Sell |
194,762
-48,445
| -20% | -$1.83M | 0.01% | 1060 |
|
|
2016
Q2 | $8.18M | Buy |
243,207
+140,671
| +137% | +$4.96M | 0.02% | 1001 |
|
|
2016
Q1 | $3.26M | Buy |
102,536
+81,486
| +387% | +$2.66M | 0.01% | 1555 |
|
|
2015
Q4 | $786K | Sell |
21,050
-4,936
| -19% | -$187K | ﹤0.01% | 2814 |
|
|
2015
Q3 | $986K | Sell |
25,986
-7,060
| -21% | -$248K | ﹤0.01% | 2618 |
|
|
2015
Q2 | $945K | Buy |
33,046
+23,812
| +258% | +$663K | ﹤0.01% | 2749 |
|
|
2015
Q1 | $259K | Sell |
9,234
-1,008,036
| -99% | -$28.3M | ﹤0.01% | 3363 |
|
|
2014
Q4 | $28.1M | Sell |
1,017,270
-199,016
| -16% | -$4.93M | 0.04% | 554 |
|
|
2014
Q3 | $27.1M | Sell |
1,216,286
-10,197
| -0.8% | -$259K | 0.04% | 556 |
|
|
2014
Q2 | $35.6M | Buy |
1,226,483
+362,054
| +42% | +$9.67M | 0.05% | 435 |
|
|
2014
Q1 | $24.6M | Buy |
864,429
+629,579
| +268% | +$20.8M | 0.04% | 552 |
|
|
2013
Q4 | $9.07M | Sell |
234,850
-80,779
| -26% | -$2.89M | 0.01% | 1214 |
|
|
2013
Q3 | $10.6M | Buy |
315,629
+271,744
| +619% | +$8.66M | 0.02% | 962 |
|
|
2013
Q2 | $1.35M | Buy |
+43,885
| New | +$1.47M | ﹤0.01% | 2463 |
|
Other funds holding MDCO
D.E. Shaw & Co's MDCO Position: Q1 2020 in Review
D.E. Shaw & Co sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 85,466 shares — an estimated $7.26M sold.
D.E. Shaw & Co first reported a position in MDCO in Q2 2013 and held it in 19 quarters. The position peaked at $35.6M in Q2 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- D.E. Shaw & Co reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- D.E. Shaw & Co sold 85,466 Medicines Co shares in Q1 2020, an estimated $7.26M.
- D.E. Shaw & Co first reported a position in Medicines Co in Q2 2013 and held it in 19 quarters.
- D.E. Shaw & Co's Medicines Co position peaked at $35.6M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.